IP Library Assignment 059528/0317
Patent Assignment
Reel/Frame 059528/0317

Assignment of Assignor's Interest

Recorded: 2022-04-07 Pages: 3
Assignors
HIONIDI, YULIA
Executed: 2022-03-22
TSIPORI, OMER
Executed: 2022-03-27
KONORTY, MARINA
Executed: 2022-03-22
Assignee
UROGEN PHARMA LTD.
9 HATAASIYA ST, RA'ANANA, 4365007, ISRAEL
Covered Property (1)
Material and Method for Treating Cancer
Application: 17/546,204 →
Publication: US 2022/0202773
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Patent Security Agreement Aug 18, 2023
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064641/0263 →
Patent Security Agreement Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Amended and Restated Patent Security Agreement Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Amended and Restated Patent Security Agreement Aug 18, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072472/0233 →
Second Amended and Restated Patent Security Agreement Mar 2, 2026
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 074994/0338 →